The Steelman Lab’s goal is to identify detrimental and repair-promoting signaling pathways resulting from neuroinflammation and glial activation then modulate them in such a way as to achieve a beneficial outcome for those suffering from neurological diseases. Our specific area of interest is encephalitis. A major line of our current research is focused on multiple sclerosis, which we have been researching since 2003. We are particularly interested in uncovering how upper-respiratory viral infection, exacerbates symptoms of this disease. Another emerging aspect of our research is focused on uncovering detrimental vs. repair promoting responses that occur during viral encephalitis.

Our Principal Investigator is Andrew Steelman.

Keep up with our blog and check out our website here.